These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 8691639

  • 1. [CD26/dipeptidyl peptidase IV and thyroid peroxidase as molecular markers for differentiated thyroid carcinoma].
    Umeki K, Yamamoto I, Maruta J, Aratake Y, Ono I, Uemura Y, Tanaka T, Toyoda K, Kotani T, Noguchi S, Sakamoto F, Konoe K, Ohtaki S.
    Rinsho Byori; 1996 Jan; 44(1):42-50. PubMed ID: 8691639
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Diagnostic utility of galectin-3 and CD26/DPPIV as preoperative diagnostic markers for thyroid nodules.
    Aratake Y, Umeki K, Kiyoyama K, Hinoura Y, Sato S, Ohno A, Kuribayashi T, Hirai K, Nabeshima K, Kotani T.
    Diagn Cytopathol; 2002 Jun; 26(6):366-72. PubMed ID: 12112826
    [Abstract] [Full Text] [Related]

  • 6. CD26 (dipeptidyl peptidase IV/DPP IV) as a novel molecular marker for differentiated thyroid carcinoma.
    Tanaka T, Umeki K, Yamamoto I, Sakamoto F, Noguchi S, Ohtaki S.
    Int J Cancer; 1995 Oct 20; 64(5):326-31. PubMed ID: 7591305
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The use of a combination of galectin-3 and thyroid peroxidase for the diagnosis and prognosis of thyroid cancer.
    Weber KB, Shroyer KR, Heinz DE, Nawaz S, Said MS, Haugen BR.
    Am J Clin Pathol; 2004 Oct 20; 122(4):524-31. PubMed ID: 15487449
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue.
    Fernández PL, Merino MJ, Gómez M, Campo E, Medina T, Castronovo V, Sanjuán X, Cardesa A, Liu FT, Sobel ME.
    J Pathol; 1997 Jan 20; 181(1):80-6. PubMed ID: 9072007
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Diagnostic applicability of dipeptidyl aminopeptidase IV activity in cytological samples for differentiating follicular thyroid carcinoma from follicular adenoma.
    Maruta J, Hashimoto H, Yamashita H, Yamashita H, Noguchi S.
    Arch Surg; 2004 Jan 20; 139(1):83-8. PubMed ID: 14718282
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Detection of cytokeratin 19 and thyroperoxidase expressions in the diagnosis of thyroid diseases].
    Yang QX, Shao CK, Feng ZY, Huang BQ, Han AJ, Xiong M, Zhao WL, Wu TT.
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun 20; 25(6):678-81. PubMed ID: 15958307
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Gene expression of differentiation- and dedifferentiation markers in normal and malignant human thyroid tissues.
    Hoang-Vu C, Dralle H, Scheumann G, Maenhaut C, Horn R, von zur Mühlen A, Brabant G.
    Exp Clin Endocrinol; 1992 Jun 20; 100(1-2):51-6. PubMed ID: 1281780
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.